IN-VITRO TESTING OF CYCLOPHOSPHAMIDE ON TUMORS.KAUFMANN M; MATTERN J; VOLM M et al.1975; NATURWISSENSCHAFTEN; DTSCH.; DA. 1975; VOL. 62; NO 4; PP. 446-447; BIBL. 8 REF.Article

ZUM PROBLEM DER IN VITRO. SENSIBILITAETSTESTUNG VON TUMORENGEGEN CYCLOPHOSPHAMID, ³H-URIDINE INBAU IN RIBONUCLEINSAEURE MENSCHLICHER TUMORZELLEN NACH INKUBATION MIT 4-HYDRO-PEROXY-CYCLOPHOSPHAMID. II = ETUDE IN VITRO DE LA SENSIBILITE DES TUMEURS HUMAINES AU CYCLOPHOSPHAMIDE: EFFET DE L'HYDROPEROXY-4 CYCLOPHOSPHAMIDE SUR L'INCORPORATION DE L'URIDINE-³H DANS LES ACIDES RIBONUCLEIQUES DE CELLULES TUUMORALES HUMAINESBASTERT G; VOELCKER G; PETER G et al.1976; KREBSFORSCH. KLIN. ONKOL.; DTSCH.; DA. 1976; VOL. 85; NO 3; PP. 299-307; ABS. ANGL.; BIBL. 24 REF.Article

DIE WIRKUNG VON CYCLOPHOSPHAMID UND EINIGEN DERIVATEN AUF DIE CORTISONINDUKTION DER TYROSIN-AMINOTRANSFERASE IN DER RATTENLEBER. = L'ACTION DU CYCLOPHOSPHAMIDE ET DE QUELQUES DERIVES SUR L'INDUCTION PAR LE CORTISOL DE LA TYROSINE-AMINOTRANSFERASE DANS LE FOIE DU RATKROGER H; GRATZ R.1978; ARZNEIMITTEL-FORSCH.; DEU; DA. 1978; VOL. 28; NO 6; PP. 970-973; ABS. ANGL.; BIBL. 8 REF.Article

Effect of 4-hydroperoxycyclophosphamide on leukemic and normal human myeloid progenitor cellsDELFORGE, A; LOOS, M; STRYCKMANS, P et al.Leukemia research. 1985, Vol 9, Num 5, pp 583-586, issn 0145-2126Article

Human multilineage progenitor cell sensitivity to 4-hydroperoxycyclophosphamideROWLEY, S. D; COLVIN, O. M; STUART, R. K et al.Experimental hematology. 1985, Vol 13, Num 4, pp 295-298, issn 0301-472XArticle

In vitro effects of 4-hydroperoxycylophosphamide on concanavalin A-induced human suppressor T cellsKLAJMAN, A; DRUCKER, I; MANOR, Y et al.Cancer immunology and immunotherapy. 1984, Vol 18, Num 2, pp 113-117, issn 0340-7004Article

DIRECT IN VITRO EVIDENCE FOR DIFFERENT SUSCEPTIBILITIES TO 4-HYDROPEROXYCYCLOPHOSPHAMIDE OF ANTIGEN-PRIMED T CELLS REGULATING HUMORAL AND CELL-MEDIATED IMMUNE RESPONSES TO SHEEP ERYTHROCYTES: A POSSIBLE EXPLANATION FOR THE INVERSE ACTION OF CYCLOPHOSPHAMIDE ON HUMORAL AND CELL-MEDIATED IMMUNE RESPONSESDIAMANTSTEIN T; KLOS M; HAHN H et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 5; PP. 1717-1719; BIBL. 21 REF.Article

ACTIVATED CYCLOPHOSPHAMIDE ANTICANCER DRUGS: MOLECULAR STRUCTURE OF 4-HYDROPEROXYCLOPHOSPHAMIDE.CAMERMAN A; SMITH HW; CAMERMAN N et al.1977; ACTA CRYSTALLOGR., B; DANEM.; DA. 1977; VOL. 33; NO 3; PP. 678-683; BIBL. 17 REF.Article

STEREOCHEMISTRY OF ACTIVATED CYCLOPHOSPHAMIDE ANTITUMOR DRUGS: MOLECULAR STRUCTURE OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE.CAMERMAN A; SMITH HW; CAMERMAN N et al.1975; BIOCHEM. BIOPHYS. RES. COMMUNIC.; U.S.A.; DA. 1975; VOL. 65; NO 3; PP. 828-832; BIBL. 14 REF.Article

ELIMINATION OF ACUTE MYELOGENOUS LEUKEMIC CELLS FROM MARROW AND TUMOR SUSPENSIONS IN THE RAT WITH 4-HYDROPEROXYCYCLOPHOSPHAMIDESHARKIS SJ; SANTOS GW; COLVIN M et al.1980; BLOOD; USA; DA. 1980; VOL. 55; NO 3; PP. 521-523; BIBL. 17 REF.Article

RELATIVE SUSCEPTIBILITIES OF T CELL SUBSETS IN VOLVED IN DELAYED-TYPE HYPERSENSITIVITY TO SHEEPS RED BLOOD CELLS TO THE IN VITRO ACTION OF 4-HYDROPEROXYCYCLOPHOSPHAMIDEKAUFMANN SHE; HAHN H; DIAMANTSTEIN T et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 125; NO 3; PP. 1104-1108; BIBL. 17 REF.Article

RESISTENZTESTUNG MENSCHLICHER TUMOR- UND KNOCHENMARKSZELLEN GEGENUEBER ZYTOSTATIKA. = TEST DE RESISTANCE DES CELLULES MEDULLAIRES ET TUMORALES HUMAINES AUX CYTOSTATIQUESKAUFMANN M; KUBLI F.1978; FORTSCH. D. MED.; DTSCH.; DA. 1978; VOL. 96; NO 15; PP. 823-826; ABS. ANGL.; BIBL. 19 REF.Article

SENSIBILITAETSTESTUNG HISTOLOGISH CHARAKTERISIERTER OVARIAL- UND KORPUSKARZINOME GEGEN 4-HYDROPEROXICYCLOPHOSPHAMID, AMETHOPTERIN, MITOPODOZID UND 4-O-DIMETHYL-1-O-(4,6-O-2-THENYLIDEN-BETA -D-GLUCOPYRANOSYL) EPIPODOPHYLLOTOXIN MIT DER PRIMAERKULTURTECHNICK. = ESSAI DE SENSIBILITE DE CARCINOMES DE L'OVAIRE ET DU CORPS DE L'UTERUS CARACTERISE HISTOLOGIQUEMENT ENVERS L'HYDROPEROXY-4 CYCLOPHOSPHAMIDE, L'AMETHOPTERINE, LE MITOPODOZIDE ET LA O-DIMETHYL-4 O-(4,O 6,O-THENYLIDENE-2 D-GLUCOPYRANOSYL)-EPIPODOPHYLLOTOXINE PAR LA TECHNIQUE DE CULTURE PRIMAIREJANKOWSKI RP; WETZEL V; VAHRSON H et al.1977; STRAHLENTHERAPIE; DTSCH.; DA. 1977; VOL. 153; NO 8; PP. 545-552; ABS. ANGL. FR.; BIBL. 14 REF.Article

Survival of highly proliferative colony forming cells after treatment of bone marrow cells with 4-hydroperoxycyclophosphamideKOMATSU, N; SUDA, T; SUDA, J et al.Cancer research (Baltimore). 1987, Vol 47, Num 23, pp 6371-6376, issn 0008-5472Article

In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell linesMIN-JIAN XU; ALBERTS, D. S; LIU, R et al.Cancer chemotherapy and pharmacology. 1989, Vol 25, Num 2, pp 89-94, issn 0344-5704Article

DNA cross-linking and single-strand breaks induced by teratogenic concentrations of 4-hydroperoxycyclosphosphamide and phosphoramide mustard in postimplantation rat embryosLITTLE, S. A; MIRKES, P. E.Cancer research (Baltimore). 1987, Vol 47, Num 20, pp 5421-5426, issn 0008-5472Article

Intrathecal administration of 4-hydroperoxycyclophosphamide in rhesus monkeysARNDT, C. A. S; COLVIN, O. M; BALIS, F. M et al.Cancer research (Baltimore). 1987, Vol 47, Num 22, pp 5932-5934, issn 0008-5472Article

Mutagenic and toxic effects of 4-hydroperoxycyclophosphamide and of 2,4-tetrahydrocyclohexylamine (ASTA-Z-7557) on human lymphocytes cultured in vitroPEROCCO, P; PANE, G; SANTUCCI, M. A et al.Experimental hematology. 1985, Vol 13, Num 10, pp 1014-1017, issn 0301-472XArticle

Antitumor effect and metabolic activation of cyclophosphamide and 4-hydroperoxycyclophosphamide in the human breast carcinoma (MX-1)-nude mouse system = Effet antitumoral et activation métabolique du cyclophosphamide et du 4-hydroperoxycyclophosphamide dans le système tumeur du sein humain MX-1-souris nudeKUBOTA, T; HANATANI, Y; TSUYUKI, K et al.Gann. 1983, Vol 74, Num 3, pp 437-444, issn 0016-450XArticle

CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrowROWLEY, S. D; ZUEHLSDORF, M; BRAINE, H. G et al.Blood. 1987, Vol 70, Num 1, pp 271-275, issn 0006-4971Article

Comparative in vitro effects of cyclophosphamide derivatives on murine bone marrow-derived stromal and hemopoietic progenitor cell classesDE JONG, J. P; NIKKELS, P. G. J; BROCKBANK, K. G. M et al.Cancer research (Baltimore). 1985, Vol 45, Num 9, pp 4001-4005, issn 0008-5472Article

In vitro effects of 4-hydroperoxycyclophosphamide on the morphology and function of human peripheral blood mononuclear phagocytic cells (macrophages)JASON, M; ANDREWS, B. S; COLVIN, M et al.Cancer research (Baltimore). 1984, Vol 44, Num 9, pp 3936-3941, issn 0008-5472Article

Effect of Lonidamine on the cytotoxicity of four alkylating agents in vitroROSBE, K. W; BRANN, T. W; HOLDEN, S. A et al.Cancer chemotherapy and pharmacology. 1989, Vol 25, Num 1, pp 32-36, issn 0344-5704Article

Dose-response effects of 4-hydroperoxycyclophosphamide on human T and B cell function in vitroKODO, H; BONAVIDA, B; COLVIN, M et al.International journal of immunopharmacology. 1985, Vol 7, Num 4, pp 555-560, issn 0192-0561Article

Synergism between 4-hydroperoxycyclophosphamide and cisplatin : importance of incubation sequence and measurement of cisplatin accumulationPETERS, R. H; STUART, R. K.Biochemical pharmacology. 1990, Vol 39, Num 3, pp 607-609, issn 0006-2952Article